Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 9;8(10):e3219.
doi: 10.1371/journal.pntd.0003219. eCollection 2014 Oct.

Chagas disease and the london declaration on neglected tropical diseases

Rick L Tarleton  1 , Ricardo E Gürtler  2 , Julio A Urbina  3 , Janine Ramsey  4 , Rodolfo Viotti  5
Affiliations

Chagas disease and the london declaration on neglected tropical diseases

Rick L Tarleton et al. PLoS Negl Trop Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR (2008) The neglected tropical diseases of latin america and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300. - PMC - PubMed
    1. Urbina JA (2010) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115: 55–68. - PubMed
    1. Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC, Rassi A, et al. (2009) The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 104 Suppl 1: 319–324 BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease. Population Health Research Institute. Available: http://clinicaltrials.gov/. Identifier: NCT00123916. - PubMed
    1. Riarte A (2013) TRAENA: Placebo-controlled evaluation of impact of benznidazole treatment on long-term disease progression in adults with chronic Chagas disease. In: Proceedings of the 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene; November 13–17, 2013; Washington, DC.
    1. Torrico F (2013) E1224–Results of proof of concept clinical trial in patients with chronic indeterminate Chagas disease. In: Proceedings of the 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene; November 13–17, 2013; Washington, DC. Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease. Drugs for Neglected Diseases Initiative. Available: http://clinicaltrials.gov/. Identifier: NCT01489228.

Publication types

LinkOut - more resources